Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
J Law Med ; 13(4): 465-70, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16756215

RESUMO

Ensuring the safety of staff and patients has become a major problem for hospitals in China. This article examines whether one of the reasons for this violence may be the emerging injustice and inequality that have manifested in the Chinese health care system as a result of privatisation reforms since the early 1980s. It considers approaches to these issues that may assist the Chinese Government, and other nations contemplating similar policy changes, to create efficient but equity-based health care systems that minimise collateral trauma to patients and their families.


Assuntos
Política de Saúde/tendências , Hospitais Públicos/organização & administração , Relações Médico-Paciente , Privatização/legislação & jurisprudência , Segurança/estatística & dados numéricos , Justiça Social/tendências , Cobertura Universal do Seguro de Saúde/legislação & jurisprudência , Violência/estatística & dados numéricos , China/epidemiologia , Hospitais Públicos/economia , Humanos , Segurança/economia , Justiça Social/economia , Fatores Socioeconômicos , Cobertura Universal do Seguro de Saúde/tendências , Violência/economia
2.
J Biol Chem ; 282(20): 15238-47, 2007 May 18.
Artigo em Inglês | MEDLINE | ID: mdl-17384413

RESUMO

An important feature of chemokines is their ability to bind to the glycosaminoglycan (GAG) side chains of proteoglycans, predominately heparin and heparan sulfate. To date, all chemokines tested bind to immobilized heparin in vitro, as well as cell surface heparan sulfate in vitro and in vivo. These interactions play an important role in modulating the action of chemokines by facilitating the formation of stable chemokine gradients within the vascular endothelium and directing leukocyte migration, by protecting chemokines from proteolysis, by inducing chemokine oligomerization, and by facilitating transcytosis. Despite the importance of eotaxin in eosinophil differentiation and recruitment being well established, little is known about the interaction between eotaxin and GAGs and the functional consequences of such an interaction. Here we report that eotaxin binds selectively to immobilized heparin with high affinity (K(d) = 1.23 x 10(-8) M), but not to heparan sulfate or a range of other GAGs. The interaction of eotaxin with heparin does not promote eotaxin oligomerization but protects eotaxin from proteolysis directly by plasmin and indirectly by cathepsin G and elastase. In vivo, co-administration of eotaxin and heparin is able to significantly enhance eotaxin-mediated eosinophil recruitment in a mouse air-pouch model. Furthermore, when heparin is co-administered with eotaxin at a concentration that does not normally result in eosinophil infiltration, eosinophil recruitment occurs. In contrast, heparin does not enhance eotaxin-mediated eosinophil chemotaxis in vitro, suggesting protease protection or haptotactic gradient formation as the mechanism by which heparin enhances eotaxin action in vivo. These results suggest a role for mast cell-derived heparin in the recruitment of eosinophils, reinforcing Th2 polarization of inflammatory responses.


Assuntos
Quimiocinas CC/metabolismo , Quimiotaxia de Leucócito , Eosinófilos/metabolismo , Heparina/metabolismo , Heparitina Sulfato/metabolismo , Processamento de Proteína Pós-Traducional , Animais , Anticoagulantes/química , Anticoagulantes/metabolismo , Anticoagulantes/farmacologia , Catepsina G , Catepsinas/metabolismo , Quimiocina CCL11 , Quimiocinas CC/química , Quimiocinas CC/farmacologia , Quimiotaxia de Leucócito/efeitos dos fármacos , Endotélio Vascular/metabolismo , Endotélio Vascular/patologia , Eosinófilos/patologia , Fibrinolisina/metabolismo , Heparina/química , Heparina/farmacologia , Heparitina Sulfato/química , Heparitina Sulfato/farmacologia , Inflamação/metabolismo , Inflamação/patologia , Masculino , Mastócitos/metabolismo , Mastócitos/patologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Transgênicos , Modelos Biológicos , Ligação Proteica/efeitos dos fármacos , Processamento de Proteína Pós-Traducional/efeitos dos fármacos , Serina Endopeptidases/metabolismo , Células Th2/metabolismo , Células Th2/patologia
3.
Med J Aust ; 185(6): 320-3, 2006 Sep 18.
Artigo em Inglês | MEDLINE | ID: mdl-16999673

RESUMO

Australia is largely self-sufficient in its supply of safe, fresh blood products because of the goodwill of non-remunerated, volunteer donors, plus rigorous testing and processing standards. CSL Limited is the sole provider of plasma fractionation services in Australia, enjoying exclusive rights under the Plasma Fractionation Agreement with the Australian Government. In the Australia-United States Free Trade Agreement (AUSFTA), Australia agreed to review its current contract with CSL Limited, and to recommend to the states and territories that the process be opened up to overseas tender. Overseas tenders for off-shore fractionation services are likely to be highly competitive due to their low manufacturing costs and accumulated expertise. Off-shore fractionation could compromise the safety of Australia's blood supply through delays in processing and transportation, issues related to quality control, and even the siphoning of stock to overseas markets. This could compromise the long-term care of Australian patients and create a serious national security risk in the event of a terrorist attack or natural disaster. Australia's AUSFTA obligation to recommend changes does not equate to an obligation to actually proceed. The states and territories should carefully consider whether such changes would be in our national interest. The long-term security of the Australian people in the current security environment is dependent on continuance of an on-shore fractionation plant and appropriate back-up facilities.


Assuntos
Doadores de Sangue/legislação & jurisprudência , Doadores de Sangue/provisão & distribuição , Comércio/legislação & jurisprudência , Regulamentação Governamental , Política de Saúde/legislação & jurisprudência , Austrália , Bancos de Sangue/legislação & jurisprudência , Humanos , Cooperação Internacional , Programas Nacionais de Saúde/legislação & jurisprudência , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA